Frazier Lifesciences Acquisition Corporation (FLAC)

9.88 +0.01 (+0.10%) At close: 04:00PM EDT

Frazier Lifesciences Acquisition Corporation

Two Union Square
Suite 3200 601 Union Street
Seattle, WA 98101
United States
206 621 7200
https://www.frazierlifesciencesacquisition.com

Sector(s): Financial Services
Industry: Shell Companies
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. James N. Topper M.D., Ph.D.	CEO & Chairman	N/A	N/A	1962
Mr. David J. Topper	CFO & Director	N/A	N/A	1958
Mr. Gordon Empey J.D.	VP & Gen. Counsel	N/A	N/A	1969

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.

Corporate governance

Frazier Lifesciences Acquisition Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.